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ABSTRACT Interactions of the local anesthetic tetracaine with unilamellar vesicles made of dimyristoyl or dipalmitoyl phos-
phatidylcholine (DMPC or DPPC), the latter without or with cholesterol, were examined by following changes in the drug’s ﬂuo-
rescent properties. Tetracaine’s location within the membrane (as indicated by the equivalent dielectric constant around the
aromatic ﬂuorophore), its membrane:buffer partition coefﬁcients for protonated and base forms, and its apparent pKa when
adsorbed to the membrane were determined by measuring, respectively, the saturating blue shifts of ﬂuorescence emission at
high lipid:tetracaine, the corresponding increases in ﬂuorescence intensity at this lower wavelength with increasing lipid, and the
dependence of ﬂuorescence intensity of membrane-bound tetracaine (TTC) on solution pH. Results show that partition co-
efﬁcients were greater for liquid-crystalline than solid-gel phase membranes, whether the phase was set by temperature or lipid
composition, and were decreased by cholesterol; neutral TTC partitioned into membranes more strongly than the protonated
species (TTCH1). Tetracaine’s location in the membrane placed the drug’s tertiary amine near the phosphate of the headgroup,
its ester bond in the region of the lipids’ ester bonds, and associated dipole ﬁeld and the aromatic moiety near fatty acyl carbons
2–5; importantly, this location was unaffected by cholesterol and was the same for neutral and protonated tetracaine, showing
that the dipole-dipole and hydrophobic interactions are the critical determinants of tetracaine’s location. Tetracaine’s effective
pKa was reduced by 0.3–0.4 pH units from the solution pKa upon adsorption to these neutral bilayers, regardless of physical
state or composition. We propose that the partitioning of tetracaine into solid-gel membranes is determined primarily by its steric
accommodation between lipids, whereas in the liquid-crystalline membrane, in which the distance between lipid molecules is
larger and steric hindrance is less important, hydrophobic and ionic interactions between tetracaine and lipid molecules predominate.
INTRODUCTION
Many drugs interact with membranes to pass into or through
cells or to penetrate to hydrophobic sites on membrane-
associated proteins. Local anesthetics, class I antiarrhythmic
agents, and other amphipathic amines exert their primary
actions on ionic Na1 channels either from the cytosol, after
permeating the plasma membrane, or from within the mem-
brane phase itself (1–6). Equally important may be the pro-
posed role of the membrane in controlling the rate-limiting
step for dissociation of the drug from its target protein, e.g.,
via the so-called ‘‘hydrophobic pathway’’ of escape from
voltage-gated Na1 channels (3,7).
The wish to understand the molecular mechanisms by
which local anesthetics block different types of ion channels
(8,9) and the mechanisms by which irreversible nerve injury
is caused by local anesthetics (10) has driven the study of
local anesthetic-membrane interactions for over three de-
cades. The dynamics of drug:membrane interactions have
been investigated previously by others using a variety of
physical methods, including x-ray diffraction (11,12), NMR
(13–27), electron paramagnetic resonance (28–33), and
Fourier transform infrared spectroscopy (24,34–38). These
methods, although providing good spatial resolution, are very
slow and cannot resolve any kinetic processes in this inter-
action. Furthermore, these earlier studies had not integrated
the roles of membrane dynamics and drug ionization, and
often the membranes were made of a heterogeneously ac-
ylated lipid, e.g., egg phostphatidyl choline, and included no
cholesterol. In these studies we have used the intrinsic
ﬂuorescence of the local anesthetic tetracaine (39,40) to study
its interactions with bilayer membranes made of pure lipids,
sometimes including cholesterol, and to validate its use for
later kinetic studies.
The interaction of tetracaine with lipid bilayers is com-
plicated by two factors. One is that tetracaine, an amphi-
pathic molecule, has detergent properties dependent on its
concentration and on the solution pH. For example, charged
tetracaine may form micelles (29,41), for which it has a
different behavior than as monomers in solution, and also
can dissolve membranes through its detergent action. As a
consequence of the second property, at high concentrations
tetracaine may induce signiﬁcant changes in membrane struc-
ture and phase-transition parameters, even forming tetracaine-
lipid mixed micelles (23,29,41–44). Additionally, tetracaine
at high concentration can form dimers, at least in the mem-
brane (26). This is potentially problematic since techniques
used previously to study the interaction of local anesthetics
with model or nerve membranes, e.g., NMR, quite frequently
used high concentrations of the investigated substance and
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therefore would have studied phenomena that do not occur
during normal local anesthesia.
Previously we examined the equilibrium interactions of a
series of structurally related local anesthetics with micelles
made from different detergents to weigh the importance of
hydrophobicity, the dipole moment of the local anesthetics’
‘‘linker’’ moiety (amide versus ester or ether), and drug ion-
ization on the afﬁnity and the ‘‘depth’’ from the surface for
drug binding to micelles (45), following earlier studies by
Garcia-Soto and Fernandez (46). We found that both hy-
drophobicity and ionization of these drugs, as well as the type
of and charge on the detergent, affected the equilibrium afﬁnity
and depth, with more hydrophobic local anesthetics, in the
uncharged form, binding tighter and deeper within micelles,
and drug protonation positioning molecules closer to the
micellar surface. Drug molecules containing stronger dipoles
(i.e., the amide bond in procainamide . the ester bound in
procaine) had both weaker binding afﬁnity and a shallower
interfacial depth when bound. The pKa of local anesthetics
bound to neutral detergents was lower than in solution.
In this work we have extended the micellar study by ex-
amining the interaction of tetracaine with model membranes
made of dipalmitoylphosphatidyl choline (DPPC), without
or with cholesterol, or dimyristoylphosphatidyl choline
(DMPC) to answer the following questions: 1), How does
the molecular composition or physical state of the membrane
affect tetracaine’s adsorption to and distribution within the
membrane? 2), How does the state of drug ionization affect
its afﬁnity and binding position? 3), How is tetracaine’s ion-
ization altered by membrane adsorption, i.e., is the effective
pKa of membrane-bound tetracaine different from that of free
tetracaine in aqueous solution?
The intrinsic ﬂuorescence of drug molecules containing
conjugated electron orbitals is a useful probe of both the
drug’s state of ionization and the polarity of the medium
surrounding the ﬂuorophore (39,40). The ﬂuorescence in-
tensity (I) is a function of the quantum efﬁciency of photon
emission, which is reduced both by increasing solvent po-
larity and by drug ionization. Protonation of local anesthetics
causes electron shifts, which results in decreased I, primarily
through the absorbance process (47) with minimal spectral
shifts. By measuring pH-dependent changes in I, we are
able to establish the pKa of TTC in either the aqueous or
membrane-bound state. In addition, the wavelength of
maximum emission (lmax) is governed by the ﬂuorescence
transition dipole (p*/p), which is reduced by interaction
with polar solvent molecules. We exploited the dependence
of lmax on local polarity by interpreting the blue shifts of
lmax in the presence of drug-adsorbing membranes as a re-
ﬂection of the average polarity of the membrane regions
surrounding the aromatic moieties of the drug, calibrated by
its blue shift in homogeneous organic or mixed solvents of
known dielectric constant. The results give a picture of tet-
racaine:membrane dynamics, mostly consistent with previ-
ous reports but with some important differences, and extend
the ﬁndings to show the relative importance of the physical
state and composition of the membrane for drug interactions.
Furthermore, the ﬁndings validate this ﬂuorescence method
for investigating interactions of many other drugs and mem-
branes, with no special requirements for labeled drugs or exo-




Tetracaine (HCl) was obtained from Sigma-Aldrich Chemicals (St. Louis,
MO). All phospholipids (PL) were obtained from Avanti Polar Lipids
(Alabaster, AL), were .99% pure dissolved in CHCl3, and were stored at
20C and used as received. Cholesterol was obtained from Avanti Polar
Lipids as a powder. Radio-labeled 14C-dipalmitoyl phosphatidylcholine in
toluene:methanol (1:1) was purchased from Perkin-Elmer Life and Analyt-
ical Sciences (Boston, MA).
Solutions
All experiments were conducted in a standard aqueous medium (SAM),
which contained 150 mM NaCl in doubly deionized (18 Mohm-cm), highly
puriﬁed, pyrogen-free water (Water Systems 5601, Millipore, Woburn,
MA), buffered with a combination of 3 Good buffers (48), 2 mM CAPS
(3-(cyclohexylamino)-propanesulfonic acid, pKa ¼ 10.4), 2 mM BICINE
(N,N-bis(2-hydroxyethyl) glycine, pKa ¼ 8.35), and 2 mM MES (2-(N-
morpholino)-ethanesulfonic acid, pKa ¼ 6.15) monohydrate (all obtained
from Calbiochem-Behring, La Jolla, CA) to provide a constant buffering
capacity over the broad pH range 5.5–11.
Membrane preparation
Large unilamellar vesicles (LUVETs), ;100-nm diameter, were created by
the extrusion technique of Hope et al. (49), using 14C-radiolabeled DPPC as
a tracer to quantify yields and determine the concentration of LUVETs. Fifty
milligrams of DPPC (an additional 10 mg cholesterol in CHCl3 was added
when making DPPC-cholesterol LUVETs) and tracer were placed in a
round-bottom ﬂask and vortexed together, and the chloroform in which they
were delivered was evaporated under N2 gas. Twenty milliliters of SAM
were then added to the lipid residue and the lipid-SAM mixture was heated in
a water bath to 50C–55C, a temperature above the solid gel-liquid crystal
transition temperature (41C for DPPC) and repeatedly vortexed until all lipid
was in solution. A sample of the resulting mixture was counted on a Beckman
Model LS 6500 liquid scintillation counter (10 mL/5 ml Aquasol 2, NEN
Dupont, Boston, MA, or EcoLiteliquid scintillation cocktail, ICN Biomed-
icals, Costa Mesa, CA) to determine the speciﬁc radioactivity (cpm/mmoles
lipid), the conversion factor to be used for calculation of lipid concentration.
The SAM-lipid mixture was alternatively frozen and thawed at least ﬁve
times to ensure complete hydration and equilibration (especially in the
presence of cholesterol). The mixture was frozen in a dry-ice/acetone bath
and thawed at 50C–55C in a water bath. The lipid mixture was then
extruded at least 10 times through a Northern Lipids (Vancouver, B.C.)
extruder ﬁtted with two 0.1-mm polycarbonate ﬁlters (BioRad, Westbury,
NY) and driven by a pressure of 400 psi, supplied by N2 gas, to produce
LUVETs. The extruder was heated to 50C for the extrusion steps. A sample
of this LUVET stock was counted by liquid scintillation to determine the
concentration of phospholipid in the ﬁnal membrane suspension. The
LUVETs were allowed to cool and were stable overnight when stored at
4C. To obtain a higher concentration of LUVET, two or more batches of
LUVETs were centrifuged and resuspended in a smaller volume of SAM.
The DMPC LUVETs were made similarly with 14C-radiolabeled DPPC as a
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tracer, except that the water bath temperature was set at 35C during the
freezing/thawing process.
Optical measurements
To avoid light scattering caused by vesicles, front-face illumination was
used with a triangular cuvette (45, 45, and 90) (50). Fluorescence emis-
sion spectra were obtained with excitation at 302 nm using an Aminco spec-
troﬂuorometer (model SPF-500 C) with a xenon lamp and direct temperature
control of the cuvette (Aminco, Urbana, IL).
Tetracaine’s equilibrium partitioning
The afﬁnity of tetracaine for the model membranes was quantitated by
determining spectroﬂuorometrically the partition coefﬁcient (Kp) of the drug
into the membrane under different conditions, as described here. Fluores-
cence both increased in intensity and shifted to shorter wavelengths in the
presence of membranes (LUVETs) (Fig. 1). The wavelength of maximum
tetracaine ﬂuorescence (lmax) is shifted from 370 nm, in aqueous solutions,
to ;350 nm when adsorbed to high concentrations of DPPC membranes
(Fig. 1 A).
Suspensions of LUVETs containing different concentrations of lipid were
formed initially in SAM at pH 5.5 or 11. Each suspension was scanned
spectroﬂuorometrically, and then to each aliquot 1 mM tetracaine stock
solution in SAM was added to bring the ﬁnal total drug concentration of up
to 10 or 20 mM (speciﬁc tetracaine concentrations are stated in the text).
After incubation at a speciﬁc temperature, each sample was then assayed
spectroﬂuorometrically. Difference spectra were obtained by subtracting cor-
responding spectra of LUVETs alone from those of tetracaine-LUVETs.
Both the ﬂuorescence intensity at 350 nm and the wavelength of maximum
emission (lmax) were taken from the difference spectra smoothed by third
polynomial functions, each with Origin software (version 7.5, Origin,
Northampton, MA). All the experiments were repeated at least three times.
We initially determined that the relationship between ﬂuorescence
intensity at 350 nm and [tetracaine] was linear at these low concentrations
(up to 20 mM, data not shown). We then analyzed the ﬂuorescence intensity
data to calculate the relative concentrations of bound and free tetracaine
molecules. This was done by ﬁrst normalizing each set of ﬂuorescence
spectra for different membrane/drug ratios by the spectra representing totally
membrane-bound drug (high lipid/tetracaine) or drug in aqueous solution
alone. From every experimental spectrum, which represented the weighted
sum of the ﬂuorescence from membrane-bound molecules plus that from
free molecules, we calculated the ratio of bound to free molecules, using the
following derivation:
Iexp ¼ Cm3 Im1Ca3 Ia; (1)
where Iexp¼ measured ﬂuorescence intensity, Im is the limiting ﬂuorescence
intensity/mole, assuming all tetracaine is in the membrane, and Ia is the
ﬂuorescence intensity/mole tetracaine in SAM, i.e., when no membranes are
present.
If Ca ¼ moles of tetracaine in solution (‘‘free’’) and Cm ¼ moles of
tetracaine in membrane, then the membrane:solution partition coefﬁcient,
Kp, deﬁned in terms of mole fractions, is Kp[ ðCm=PLÞ=ðCa=H2OÞ, for the





where PL/H2O ¼ mole fraction of membrane lipid in SAM. From mass
conservation, Cm ¼ T  Ca, where T ¼ total moles of tetracaine. Substitut-
ing in Eq. 1 gives
Iexp ¼ ðT  CaÞIm1Ca 3 Ia ¼ T 3 Im1CaðIa  ImÞ: (3)
Similarly,
Iexp ¼ Cm 3 Im1 ðT  CmÞIa ¼ CmðIm  IaÞ1 T 3 Ia: (4)
Rearranging Eqs. 3 and 4 gives
Ca ¼ Iexp  T 3
Im
Ia  Im ; and (5)
Cm ¼ Iexp  T 3
Ia
Im  Ia : (6)
FIGURE 1 (A) Typical ﬂuorescence emission spectra (solid lines) of 1.0
mM tetracaine in the absence and presence of increasing DPPC-Chol
LUVETs, pH 5.5, 23C. From bottom to top, the total lipid concentration of
DPPC-Chol LUVETs was 0, 3.88, 7.76, 10.4, 12.9, and 15.5 mM,
respectively. The ﬂuorescence emission maxima are shown for polynomial
ﬁtting of the curves. The intensity at lower wavelength, e.g., at 350 nm,
increases with membrane concentration. The broken line shows the
spectrum for aqueous TTCH1 scaled to the right vertical axis. (B) Solid
lines, ﬂuorescence spectra of 3.88 mM DPPC-Chol LUVET alone (bottom-
most trace) and, from bottom to top, with [TTCH1] ¼ 1, 3, 5, 7, 9, and
11 mM, respectively, at pH 5.5, 23C; dotted lines, ﬂuorescence dif-
ference spectra after subtraction of emission spectrum of LUVET alone
in the same order as the unsubtracted spectra shown by the solid lines.
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Substituting Eqs. 5 and 6 into Eq. 2 gives
Kp ¼ Iexp  T 3
Ia
Im  Ia 3
Ia  Im




Rearranging Eq. 7 gives
Iexp ¼ H2O 3 T 3
Ia1Kp 3 T 3 Im 3 PL
Kp 3 PL1H2O
(8)
Iexp ¼ H2O 3
Ia1Kp 3 Im 3 PL
Kp 3 PL1H2O
3 T: (9)
The slope of Iexp versus T
¼ H2O 3
Ia1Kp 3 Im 3 PL
Kp 3 PL1H2O
: (10)
Since Ia can be experimentally measured, we can obtain different slopes
at different vesicle concentrations, then solve the system of equations to
obtain Kp, and Im. Ia and Im were dependent on instrumental settings, like
gain factors, intensity of light sources, and on experimental conditions, like
pH, membrane composition, and membrane ﬂuidity. However, for one
ﬂuorometer with ﬁxed instrument settings, with which ﬂuorescence spectra
were collected at multiple lipid concentrations, Ia and Im vary only with
experimental conditions, like pH, membrane composition, and membrane
ﬂuidity, allowing calculation of Kp from Eq. 10, above. One emission
spectrum can be collected within 1 min, and we determined that the samples
used here are stable for more than 30 min. So no calibration was needed from
one operating of the instrument to another and within one operating of the
ﬂuorometer. To obtain best signal/background ratio, Ia and Im were obtained
at different instrumental settings, so their values are not comparable for
the different scenarios.
Equivalent dielectric constants
Using solutions of mixtures of dioxane (e¼ 2.2) and buffer (e¼ 78), as well
as pure organic solvents, to produce solutions of known dielectric con-
stant (ex) (see Fig. 6), a set of calibration curves was created establishing
the relationship between lmax of tetracaine and dielectric constants (45). The
limiting, minimum values of lmax in the ﬂuorescence spectra from the
highest lipid/tetracaine ratio, representing maximum ‘‘membrane-bound’’
drug molecules, were then used to calculate the equivalent bulk dielectric
constant around the ﬂuorophore, the aromatic moiety of the membrane-
bound drug, providing an estimate of the ‘‘nesting position’’ of the local
anesthetic when adsorbed to the bilayer.
Optical determination of apparent pKa
Tetracaine’s apparent pKa under the various conditions was determined
using ﬂuorescence intensity as an indicator of the proportions of charged and
neutral species. Beginning at high pH values, we sequentially added aliquots
of 0.25 M HCl to a tetracaine 1 LUVET suspension, containing enough
lipid so that the ﬂuorescence contributed by membrane-bound tetracaine-
dominated total ﬂuorescence. Fluorescence spectra were then taken at each
experimentally measured pH (digital pH/millivolt meter 611, Orion Re-
search, Boston, MA) and the corresponding changes in peak ﬂuorescence
intensity recorded. Changes in this intensity as a function of pH were ﬁt by a
Langmuir isotherm, and the apparent pKas were determined from this ﬁt.
Because total ﬂuorescence was almost exclusively from membrane-bound
tetracaine, regardless of pH, the ﬂuorescence intensity dependence on pH
reﬂects the ionization state of membrane-bound drug. In contrast, in the
cases where lipid was increased at a ﬁxed pH, the increase in ﬂuorescence
intensity resulted from the increase in membrane-bound tetracaine of only
one ionization species, since the buffered pH was 2–3 pH units above or
below the apparent pKa.
Bulk separation method to determine Kp
Bulk separation of membrane-bound tetracaine from free tetracaine was used
to obtain the partition coefﬁcient directly, for comparison with that obtained
by the ﬂuorescence method described above. When making DPPC LUVET
for this procedure, 30 ml of 3H2O was added to the DPPC suspension before
extruding LUVETs to determine the aqueous volume entrapped in the pel-
leted LUVETs after centrifugation. Tetracaine was added to 1.5 ml of DPPC
LUVET (2.94 mM) at pH 11 to a ﬁnal nominal concentration of 4 mM and
incubated at 23C for 2 min, then centrifuged at 23C with Beckman Avanti
J-25, rotor JA20.1 at 51,500 3 g for 30 min. The supernatant was decanted
and mixed with an equal volume of 40 mM sodium lauryl sulfate (SDS) in
SAM, and the pellet was also dissolved in 2 ml of 20 mM SDS in SAM. At
this concentration SDS forms micelles which both greatly enhance the
ﬂuorescence of the tetracaine (45) and also free it by dissolving the mem-
branes. The ﬂuorescence spectra of the processed supernatant and pellet
were scanned, a parallel control experiment conducted without added tet-
racaine, and the respective control spectra subtracted from those with tet-
racaine; tetracaine concentrations in supernatant and pellet were calculated
using a standard curve of ﬂuorescence intensity at 350 nm of tetracaine,
0–10 mM, in 20 mM SDS in SAM. The aqueous volume entrapped in the
pellet was calculated from the pelleted 3H2O, using liquid scintillation
counting, and the aqueous entrapped tetracaine was subtracted from the
total tetracaine in the pellet. Kp could be calculated by the deﬁnition of Eq. 2
(see above experimental design).
Statistical analysis
The signiﬁcance of differences between parameters measured in different
membranes or between physical conditions was determined by applying
Student’s unpaired t-test, with p , 0.05 as the criterion for a signiﬁcant
difference.
RESULTS
General ﬂuorescence changes with
membrane adsorption
The adsorption of tetracaine to all of the different membranes
used here caused generally similar changes in the drug’s
ﬂuorescence. The general pattern was an increase in the
intensity and a ‘‘blue’’ shift to shorter emission wavelengths,
with increasing concentration of membrane (Fig. 1 A). An
increase in tetracaine concentration, from 1 to 20 mM, a
range that had no detectable self-quenching, led to a pro-
portional increase in I (Fig. 1 B), which was used to deter-
mine partition coefﬁcients (see below). These ﬂuorescence
emission changes reached limiting lmax values at high re-
lative concentrations of lipid (Fig. 2), whereas their intensity,
Iexp, saturated at even higher lipid concentrations (Fig. 1 A)
for which total ﬂuorescence was almost exclusively from
membrane-bound drug.
The disparity between the membrane concentration de-
pendence of lmax and of Iexp is a predictable outcome when
the quantum efﬁciency of membrane-bound drug, ﬂuorescing
at the lower wavelength, is far greater than that of aqueous,
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free drug. We simulated this effect in Fig. 3 by adding the
emission spectra from membrane-bound and -free tetracaine,
modeled by Gaussian functions ﬁt to the experimental re-
sults at high and at zero lipid, respectively, and weighted by
their calculated concentrations (as mole fractions) using a
partition coefﬁcient that we calculated (Kp ¼ 1.76 3 104)
from experimental data. Just as in the experimental results
(cf. Figs. 1 A and 2 A), simulated ﬂuorescence intensity con-
tinued to increase with increasing lipid after lmax had
reached its limiting value, ﬁnally saturating at;10-fold higher
concentration.
These changes in ﬂuorescence parameters were used to
quantitate tetracaine:membrane interactions, as described in
Materials and Methods, above. The distribution of tetracaine
into the membranes of different composition and/or phase
was expressed as the partition coefﬁcient for neutral or pro-
tonated drug species. The physicochemical properties of
membrane-bound drug were investigated under conditions of
high lipid:tetracaine. pH-dependent changes of ﬂuorescence
intensity were used to determine apparent pKas in different
membranes, and the limiting minimal emission wavelengths
were interpreted as average solvent polarities (dielectric con-
stant) around the membrane-bound ﬂuorophore, the aromatic
ring of the local anesthetic molecule.
Membrane partitioning of tetracaine
By monitoring tetracaine’s relative ﬂuorescence intensity at
350 nm, which increases markedly for membrane-bound
molecules (see Fig. 1 A), it was possible to calculate the
membrane-bound and free drug. Graphs of I350 against total
[tetracaine] at a high lipid/drug ratio (cf. Fig. 1 B) yield a
linear relation with a slope that depends on the speciﬁc lipid
concentration (Fig. 4; see Materials and Methods). Solving
the system of Eq. 10 at two different lipid concentrations
yields the Kp. When measured at pH values several units
below and above the apparent pKa, this partition coefﬁcient
closely approaches the partition coefﬁcients of the respective
protonated and neutral drug species. (At intermediate pH,
where both species of tetracaine coexist, the Kp equals the
distribution coefﬁcient frommembrane binding of both forms.)
This method was applied for different lipids and at different
temperatures, allowing comparisons of Kp between liquid-
crystal and solid-gel membranes.
Table 1 lists all the partition coefﬁcients determined in this
way. For each membrane composition and temperature, Kp
values were determined for TTCH1 (pH 5.5) and TTC (pH
11), at pH values;3 pH units below and 2.5 pH units above
the apparent pKa for aqueous solutions, 8.48 (see below).
Membrane phase was established by adjusting the temper-
ature or by using a different phospholipid and was modiﬁed
by addition of cholesterol. For example, pure DPPC forms
membranes with a phase transition temperature, Tp, of 41C
(51,52) so that the solid-gel phase exists at 23C and the
liquid-crystalline phase at 45C. Membranes of pure DMPC
have a Tp of 23C (51,52), and the partitioning of tetracaine
into these membranes in the solid-gel phase was measured at
18C and in the liquid-crystal phase at 30C.
FIGURE 2 Maximum emission wavelength (lmax) versus total lipid
concentration. (n) DPPC-Chol LUVET at constant total concentration of
1.0 mM tetracaine, pH 5.5, 23C (data from polynomial ﬁt of the curves in
Fig. 1 A); (d) DPPC LUVET at constant concentration of 4.0 mM tetracaine,
pH 11, 45C. The curves through the data points are empirical functions
used to show the asymptotes of 351 6 0.3 nm (d) and 351 6 0.6 nm (n).
FIGURE 3 Simulation of lmax and ﬂuorescence intensity dependence on
lipid concentration. Two Gaussian curves centered at 370 nm and 350 nm
(created using Origin software version 7.5) model the ﬂuorescence spectra of
aqueous tetracaine and of membrane-bound tetracaine, the latter with higher
ﬂuorescence quantum yield. The net ﬂuorescence spectra were created by
using an experimentally determined Kp and a lipid concentration, and the
simulated lmax and ﬂuorescence intensity at 350 nm, graphed versus total
membrane lipid. The simulation was carried out for DPPC, pH 11, 45C,
Kp ¼ 1.76 3 104, and [Tetracaine] ¼ 4 mM.
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Comparison with Kp determined by
bulk separation
The Kp value obtained from bulk separation of DPPC
LUVETs, at pH 11, 23C, was 1.67 6 0.21 3 104 (n ¼ 2),
the same as the value of 1.246 0.093 104 (n¼ 45) obtained
by the ﬂuorescence method (p , 0.05, Student’s t-test).
Effects of membrane phospholipid composition
and phase
With the exception of the cholesterol-containing LUVETs,
which lack a well-deﬁned phase transition, the phosphati-
dylcholine (PC) bilayer membranes undergo discrete phase
transitions, and subtransitions, from a tightly packed, highly
ordered solid-gel phase to a less ordered liquid-crystalline
‘‘ﬂuid’’ phase (52,53). We compared the partitioning of
tetracaine into the two model membranes, above and below
their transition temperatures, to discern the role of the mem-
brane’s physical state on tetracaine uptake.
The larger values of Kp in liquid-crystalline membranes
than in solid-gel membranes indicate the preferred adsorp-
tion of tetracaine into the more ﬂuid phase (Table 2). Par-
titioning for both protonated and uncharged species into the
solid-gel phase of DMPCmembranes (at 18C) was the same
as that into solid-gel DPPC membranes (at 23C) (Student’s
t-test). Partition coefﬁcients of charged and neutral local
anesthetic into DMPC membranes in the liquid-crystal state
(30C) was also the same as their respective values into
liquid-crystal DPPC membranes (45C), showing that mem-
brane phase rather than the lipid’s fatty acyl composition
primarily determines tetracaine’s partitioning.
The reduction of Kp values caused by DDPC membrane
condensation to the solid-gel phase is about twice as large
for TTCH1 (52% decrease) as for uncharged TTC (33%
decrease). The same order occurs for this phase transition
in DMPC membranes (decrease in Kp of 45% vs. 32%, re-
spectively). Both examples show the relatively larger con-
tribution of ionic interactions in the changes of afﬁnity that
accompany membrane melting.
Cholesterol’s effects on partitioning
The inclusion of cholesterol in DPPC membranes lowers
tetracaine’s partition coefﬁcients (Table 3). The addition of
cholesterol into DPPC in its solid-gel state, at 23C, reduces
partitioning of neutral TTC by a smaller amount (38%) than
the reduction of partitioning into the liquid-crystal state
(58%). For the charged species of tetracaine the reductions in
partitioning caused by cholesterol have the opposite ‘‘state
dependence’’, 21% for the solid-gel state, slightly larger than
the 15% for the liquid-crystal. These data also demonstrate
that the reduction in partitioning caused by cholesterol is
larger for uncharged TTC (by 38% at 23C, 58% at 45C),
than for TTCH1 (by 21% at 23C, 15% at 45C). Therefore,
cholesterol’s addition affects the two species of tetracaine,
uncharged and protonated, in the opposite order of the liquid-
crystal to solid-gel transition (compare Tables 2 and 3). Al-
though liquid-crystal membranes become ‘‘less ﬂuid’’ from
both the solid-gel transition (52) and the inclusion of cho-
lesterol (54,55), the different molecular ‘‘ordering’’ that under-
lie these two types of ﬂuidity changes have different effects
on tetracaine’s membrane interactions (see Discussion).
FIGURE 4 Plots of I350 versus total tetracaine concentration. The data
were obtained from DPPC-Chol LUVET at pH 5.5, 23C, and ﬁt by linear
regression analysis. n represents data obtained with a membrane (LUVET)
concentration of 3.9 mM DPPC-Chol, with a slope of 2.54 3 102 mM1
and a correlation coefﬁcient of 0.989; ¼ represents data obtained with 7.8
mM DPPC-Chol LUVET, with a slope of 4.24 3 102 mM1 and a cor-
relation coefﬁcient of 0.999.
TABLE 1 Partition coefﬁcients of tetracaine into model membranes (mean 6 SE; number of independent experiments)
LIPID pH 18C 23C 30C 45C
DMPC 11 1.29 6 0.09 3 104(10) 1.89 6 0.15 3 104 (23)
5.5 6.56 6 0.64 3 103(14) 1.18 6 0.2 3 104 (30)
DPPC 11 1.24 6 0.09 3 104 (45) 1.76 6 0.11 3 104 (28)
5.5 4.76 6 0.8 3 103 (20) 1.31 6 0.13 3 104 (30)
DPPC:Chol 11 7.49 6 0.6 3 103 (22) 1.11 6 0.1 3 104 (28)
5.5 3.84 6 0.5 3 103 (13) 1.10 6 0.09 3 104 (30)
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Effect of TTC ionization state on
adsorption afﬁnity
The effects of tetracaine’s ionization on partitioning are col-
lected in Table 4. In almost all cases the ratio of Kp for neutral
to charged tetracaine exceeds unity, showing the preferred
partitioning of the neutral form. This ratio is highest (2.6) for
solid-gel DPPC membranes and lowest, essentially 1.0, for
DPPC-cholesterol at the high temperature, 45C. The high
ratio for solid-gel DPPC primarily results from the low
absolute partitioning of TTCH1 into these membranes
(4.83 103), whereas the low ratio for DPPC-cholesterol results
from the low absolute partitioning of TTC into DPPC-cho-
lesterol at high temperature (1.1 3 104). Although both cho-
lesterol-free and cholesterol-containing membranes generally
show a higher afﬁnity for neutral over charged TTC, at high
and low temperatures, there is a consistently higher ratio
(approximately twofold) in the solid-gel compared to the
liquid-crystal phase of DPPC membranes, but a smaller dif-
ference that does not reach signiﬁcance between these ratios
for DMPC membranes (Table 4).
Ionization of membrane-bound tetracaine
The apparent pKa of tetracaine adsorbed to bilayers of var-
ious compositions was determined using ﬂuorescence meth-
ods described above and in Desai et al. (45). Titrations were
conducted from pH 6.0–11.0; extreme acidity was avoided
to eliminate titration of the secondary amino group on the
aromatic ring, and alkalinity above pH 11 was avoided to
minimize hydrolysis of tetracaine’s ester linkage (56). The
ﬂuorescence versus pH data are well ﬁt by an equation for
a single proton binding to one site with association constant
Ka (Fig. 5). Apparent pKas, determined from ﬁts of this equa-
tion to these data, are collected in Table 5. At the same tem-
perature (23C or 45C), the pKa of tetracaine in DPPC
membranes, be they solid-gel or liquid-crystal, is ;0.3–0.4
pH units below that in aqueous solution, in agreement with
the changes reported for tetracaine in multilamellar mem-
branes made from egg PC (57). The presence of cholesterol
causes no, or insigniﬁcant (0.1 pH unit), decreases in the
membrane-bound tetracaine’s pKa at these respective tem-
peratures.
Estimating tetracaine’s location in bilayers
The depth of TTC’s penetration into the bilayer at equilib-
rium binding was estimated from the limiting value of lmax
at high lipid concentrations (cf. Fig. 2), using calibration
curves for tetracaine’s ﬂuorescence in bulk solvents of known
dielectric constant (see Materials and Methods and Fig. 6).
From these lmax values we determined an ‘‘equivalent bulk
dielectric constant’’ around the local anesthetic’s aromatic
ring.
These adsorption studies were conducted in membranes
of pure DPPC and of DPPC-cholesterol at pH 5.5 and 11.0.
In all cases, and regardless of the phase of the membrane,
TABLE 2 The effect of membrane physical state: Kp (liquid-
crystalline)/Kp (solid-gel) for tetracaine in model membranes
Lipid type DMPC DPPC DPPC:Chol
pH 11 1.46 6 0.22 (10) 1.42 6 0.19 (28) 1.49 6 0.25 (22)
pH 5.5 1.8 6 0.48 (14) 2.74 6 0.72 (20) 2.85 6 0.58 (13)
TABLE 3 The effect of cholesterol: Kp (without cholesterol)/Kp
(with cholesterol) for tetracaine in model membranes
Lipid type Solid-gel Liquid-crystalline
pH 11 1.66 6 0.25 (22) 1.58 6 0.24 (28)
pH 5.5 1.24 6 0.36 (13) 1.19 6 0.21 (30)




1) in model membranes
Lipid type Solid-gel phase Liquid-crystalline phase
DPPC 2.61 6 0.61 (20) 1.35 6 0.22 (28)
DPPC:Chol 2.07 6 0.42 (13) 1.02 6 0.17 (28)
DMPC 1.97 6 0.33 (10) 1.59 6 0.4 (23)
FIGURE 5 Typical pH-dependent ﬂuorescence intensity (I) of membrane-
bound tetracaine (302 nm excit./350 nm em.) and of aqueous tetracaine (302
nm excit./370 nm em.). The equation, I ¼ I2 1 (I1  I2)/(1 1 exp((pH 
pKa)/pH)) was used to ﬁt the data to obtain pKa values, (n) 8.176 0.02 (N¼
10) for tetracaine bound to DPPC membranes at 23C; (d) 8.486 0.05 (N ¼
15) for tetracaine in SAM at 23C. The data for aqueous TTC were
normalized to unity.
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at high lipid concentrations tetracaine ﬂuoresced maximally at
;351 nm (Figs. 1 A and 2). This corresponds to a dielectric
constant, e, of.6 and,10 (Fig. 6), an apolar milieu but with
values greater than a saturated alkane, implying that the aro-
matic ﬂuorophore of bound TTC and TTCH1 is localized
well away from the aqueous interface (e ¼ 80), closer to but
not within the fatty acyl region of the membrane. The con-
stancy of this value, as much as its meaning for membrane
location, shows that protonation of the local anesthetic does
not change its position with respect to that of the lipid’s in the
bilayer.
DISCUSSION
Spectroﬂuorometry of low concentrations of tetracaine in a
suspension of membrane vesicles can be used to characterize
tetracaine-membrane interactions without separating mem-
brane-bound from free drug. Where the results of this work
can be compared to previous reports using other methods, the
ﬁndings are generally similar (see below). Partitioning mea-
sured for one condition by bulk separation in this study was
the same as that determined by ﬂuorescence, further vali-
dating the ﬂuorescence method, which thus provides a satis-
factory means to determine partitioning into the bilayer using
micromolar concentrations of drug that minimally perturb
membrane structure.
Experiments then proceeded to inquire about the inﬂuence
of membrane phase and membrane composition of drug
partitioning and about the role of cholesterol when added to
DPPC bilayers in the solid-gel or the liquid-crystal state. The
importance of drug charge for partitioning among the dif-
ferent membrane types was assessed and, reciprocally, the
effect of membrane binding on tetracaine’s ionization equi-
librium. A physicochemical measure of ‘‘location’’ in the
different membranes used here was also determined. This is
the ﬁrst time that these different behaviors have been ad-
dressed in one systematic study, and their integration allows
a more complete analysis of the interactions between local
anesthetic and membrane lipids. In this Discussion we will
relate these data to published results, both for membranes
and from our earlier work on detergent micelles and then
analyze the ﬁndings in terms of the known structural dif-
ferences among the different membrane states studied here.
Tetracaine’s partitioning into the membrane
Tetracaine partitioned more strongly into liquid-crystal than
solid-gel membranes, and the neutral species of the drug
partitioned more strongly than the charged one. (Although
local anesthetics have been reported to lower the transition
temperature of pure DPPC membranes (42,58), the concen-
trations of tetracaine used here would cause a ,1C reduc-
tion.) Thermodynamically consistent with the latter behavior,
membrane-adsorbed tetracaine was less protonated than in
solution at the same bulk pH, resulting in a lower effective
apparent pKa in the membrane. Partition coefﬁcients were
lowered when cholesterol was included in the membrane of
both solid-gel and liquid-crystalline phases (22), but this
effect of cholesterol was greater on the neutral species, whereas
the phase change from liquid-crystal to solid-gel membranes
caused by temperature reduction reduced the partitioning of
TABLE 5 pKa of tetracaine in solution and membranes (mean 6 SE; number of measurements)
Membranes
Solid-gel Liquid-crystal
T (C) Solution (SAM) DPPC DPPC-Chol* DMPC DPPC DPPC-Chol* DMPC
18 8.70 6 0.02 (16) 8.30 6 0.02 (16)
23 8.48 6 0.05 (15) 8.17 6 0.02 (10) 8.15 6 0.06 (18)
30 8.50 6 0.03 (18) 8.12 6 0.02 (12)
45 8.20 6 0.03 (11)
7.91 6 0.03 (21) 7.80 6 0.01 (19)
*No phase transition in cholesterol-containing membranes.
FIGURE 6 Calibration curves for lEmmax versus dielectric constant.
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the charged species more than the neutral one. All tetracaine
adsorbed to membranes, regardless of phase or composition,
had the same equivalent bulk dielectric constant at its aro-
matic ﬂuorophore, showing that the general locus for binding
was unchanged, even though the energy of the bound state
was altered.
Partition coefﬁcients ranged around 104 ¼ xm/xs, the ratio
of mole fraction in the membrane:mole fraction in solution,
in general agreement with earlier reports (e.g., de Paula and
Schreier (59)). At the 1–10 mM tetracaine concentration used
in these experiments, the respective drug concentrations in
the membrane will be 1 tetracaine molecule for approximately
every 500–5000 lipid molecules. At this stoichiometry the
effects of the drug on the bulk bilayer properties should be
minimal, unless there are extended effects, e.g., ramifying
through the condensed solid-gel phase. We found, however,
that the changes of ﬂuorescent intensity with increasing
[tetracaine] were consistently linear, indicating a constant
partitioning behavior over the drug range used here, unlikely
to occur if bulk properties were altered by the drug.
Although TTCH1 partitioned less than TTC, partitioning
of the charged species was still substantial. Electrophysio-
logical studies have shown the importance of the uncharged
species of smaller local anesthetics, e.g., lidocaine, for per-
meating from the extracellular space to the cytoplasmic com-
partment, the apparent locus from which blockade of ionic
Na1 channels occurs (1–3,60). Both direct studies of iso-
topically labeled tetracaine in membranes (17,24,61), bulk
separations of multilamellar membranes from free drug in
solution (57), and indirect measurements, such as monitoring
the local anesthetic-induced quenching of an intramembrane
probe (62) or studying the electrophoretic mobility of multi-
lamellar vesicles in the presence of drug (63), have shown
that charged local anesthetics bind to membranes. These and
other earlier studies (15) clearly contradict claims that only
the neutral form of amine local anesthetics interacts with a
particular phase of membranes (58). In fact, under the most
physiological of conditions used here, DPPC with choles-
terol at a mole fraction (0.28), like that in many plasma
membranes (64), and near physiological temperature, pro-
tonated and neutral tetracaine partitioned almost identically.
The charged species does permeate through membranes
considerably more slowly than the neutral one, however,
showing that surface adsorption is not the rate-limiting step
for drug permeation (65,66).
High concentrations of tetracaine, 5–10 mg tetracaine per
milliliter buffer (17–33 mM), equilibrated with planar dis-
persions of egg phosphatidyl ethanolamine (16), or 10 mg
tetracaine per milliliter equilibrated with DMPC (22), have
been used previously to determine Kp by bulk separation
methods. These high drug concentrations may cause mem-
brane disruption, as 10 mg/mL tetracaine (equal to 33 mM)
has been shown to disrupt model membrane integrity be-
cause of its detergent property (10). Such an effect has been
implicated in the irreversible nerve injury caused by local
anesthetics (67,68), whereas the concentrations of TTC (,20
mM) used in this study are close to those of the IC50 for
sodium channel blockade (69) or action potential inhibition
(70). The much higher local anesthetic concentrations used
to effect drug-induced changes in membrane parameters such
as phase transition temperature and bulk viscosity/ﬂuidity, or
even tetracaine-lipid mixed micelle formation, resulting in
drug/lipid ratios of 1:10 or higher (23,29,41,44). Although
the gross changes in membranes under these conditions have
been proposed as mechanisms of anesthetic action, it is likely
that such phenomena are minimal at ‘‘physiological’’ drug
concentrations, the concentrations that exist at the plasma
membranes of the target cells which are usually 50–100-fold
lower than drug concentrations that are injected clinically to
overcome the very poor efﬁciency for delivery of these drugs
to their active compartment (71,72).
The partitioning behavior reported here agrees qualitatively
with previous reports. The favored partitioning of neutral
TTC over the protonated form has been measured by spec-
troscopic methods for a variety of unilamellar phospholipid
membranes (73) and multilamellar preparations (16) where
lipid bilayer dispersions, not enclosed vesicles, were used
(13,62,74). Valid quantitative comparisons are not possible,
however, because many of these earlier studies used mix-
tures of different phosphatidyl cholines with undeﬁned acyl
compositions, e.g., from egg yolk, and most studies were
conducted with membranes in the solid-gel phase. Further-
more, the values reported by others as ‘‘partition coefﬁcients’’
were often measured at pH values where both charged and
neutral species contribute to the membrane uptake and
therefore are truly ‘‘distribution coefﬁcients’’.
In an earlier study of tetracaine’s binding to SDS detergent
micelles, we found that, as with membranes, neutral TTC
adsorbed 3–4 times more strongly than TTCH1, but the
bound drug had an equivalent dielectric constant, calibrated
by the method used here, of ;10–15 for TTCH1, 33–38 for
TTC, showing the micellar-bound drug’s localization in a
more polar domain than in membranes and one that changed
with drug ionization. The micelles are an imperfect model
for membranes, having only the most general features of a
hydrophobic core and polar surface that will adsorb and
orient amphipathic molecules such as local anesthetics. The
poor comparison of absolute values of parameters between
micellar- and membrane-bound drug illustrates this disparity.
Location of tetracaine in lipid bilayers
The location of membrane-bound local anesthetics has been
explored previously. Using deuterated PC membranes, Bou-
langer et al. (14) and Smith et al. (24) found NMR spectral
changes which suggested that the charged tertiary amine
group of TTCH1 resided in the area of the polar head of the
phospholipid, causing an ordering of the headgroup region,
which was conﬁrmed by Watts and Poile (75) from quad-
rupole splitting of the methylenes of the choline headgroup.
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This conformational change at the interface was accompa-
nied by a disordering of the fatty acyl chain region, creating
an overall increase in phospholipid cross sectional area and a
necessary decrease in membrane thickness. The neutral form
of TTC, however, appeared to penetrate more deeply into the
membrane, as evidenced by minimal changes in headgroup
signal but similar disordering in the fatty acyl core. Boulanger
et al. proposed a model in which the two ionization states of
TTC occupy distinct locations in the bilayer.
In Watts and Poile’s (75) investigation, however, the 2H-
NMR studies using speciﬁcally deuterated phospholipids
showed similar disturbances of a and b methylene groups of
choline, by both protonated and neutral tetracaine, suggest-
ing that either ionization state had the same depth of mem-
brane penetration and that the local anesthetic’s tertiary amine
lies close to both methylene groups. This implies a super-
ﬁcially bound membrane location for the drug in either state.
Kelusky and Smith (17,18) studied the same interaction
using speciﬁcally deuterated tetracaine. They found no pH
dependence of the quadrupole splittings of the NMR spectral
peaks representing membrane-bound TTC and they too
concluded that both ionization states of the drug acquire a
similar depth of penetration. However, Kelusky et al. (20)
undertook studies of tetracaine’s position in negatively charged
PS vesicles using the same techniques and found a signif-
icant pH dependence of quadrupole splittings. This result
suggests different membrane locations for the two ionization
states of TTC, the neutral form nesting more closely to the
glycerol backbone, with its aromatic moiety experiencing a
much more highly ordered environment. Experiments em-
ploying ESR-labeled local anesthetic analogs suggest a loca-
tion in dioleoyl PC where both charged and neutral species’
amine nitrogens are near the membrane-aqueous interface (76).
Our ﬁndings show that the aromatic group of tetracaine
experienced the same equivalent dielectric around the aro-
matic ﬂuorophore, in any state of membranes made from PC,
for both TTC and TTCH1. Calibrations with bulk solvents
showed this ‘‘equivalent’’ dielectric constant to be 6–10. Al-
though a membrane’s physical properties are anistropic com-
pared to those of small, mobile solvents, the effective polarity
can be related to charge density within membranes, as cal-
culated by White and Wimley (77,78) to better understand
the interactions between lipids and membrane proteins; the
same thermodynamic arguments can be applied to small,
reversibly bound drug molecules. The dielectric constant of
H2O is;80, and even the structured H2O of hydration at the
membrane’s surface contains molecules that can interact
with solute molecules (79,80). Mobile ions at the aqueous
interface account for a relatively high charge density there,
which falls with distance into the membrane, nearing a zero
value at the acyl chain core. This charge density gradient,
which accounts for the polar property within the membrane,
establishes the ‘‘equivalent dielectric constant’’ reported by
bound tetracaine; the steepest gradient of charge density oc-
curs at the region of the glycerol backbone and the ester
carbonyls of phospholipids. Molecular models of tetracaine
that localize the aromatic ﬂuorophore near the lower end of
this region, around carbons 2–5 of the acyl tails of PC, place
the tertiary amine N within 1–2 A˚ of the negative phosphate
in the headgroup and the dipole from tetracaine’s ester bond
in the middle of the membrane dipole ﬁeld, caused by the
aligned esters of the fatty acid-glycerol ester bonds and of the
oriented interfacial H2O molecules (81,82). More important
than an absolute location, however, the pH independence of
this equivalent e means that both charged and neutral local
anesthetic molecules are located at the same place in any
membrane made predominantly of PC, whether cholesterol
is present or not.
This conclusion is inconsistent with a charge-dependent
position for membrane-bound tetracaine (see above) and re-
quires that the hydrophobic and dipole-dipole ﬁeld interac-
tions deﬁne the location of the drug among the phospholipids
such that addition of an ionic bond between TTCH1 and PC
changes the adsorption energy without altering the position.
The energetics of tetracaine’s
membrane interactions
Equilibrium partitioning is determined by the free energy
differences between the two environments, water and the mem-
brane. Local anesthetic molecules have three physicochem-
ical properties that provide potential free energy differences
between water and membranes: 1) hydrophobicity, due to
acyl moieties on the tertiary amine nitrogen (3N) and on the
p-amino group as well as the aromatic ring; 2) polar and
charged properties due to the unshared electron pair on the
3N of neutral TTC or the charged amine group in protonated
TTCH1, and the carbonyl oxygen of the ester bond; and 3)
a dipolar property due to the charge separation at the ester
bond. Interactions of hydrophobic solutes with H2O organize
the dynamic intermolecular structures of that ﬂuid, inducing
ordered ice-like clathrates around the hydrophobic moieties,
and so entropically favoring the partitioning into the mem-
brane by ‘‘hydrophobic forces’’ (77,83,84). In contrast, there
is the potential for energy-gaining interactions between charged
or polar tetracaine and both H2O and phospholipid mole-
cules. Protonated TTCH1 in the membrane might form ionic
bonds with the anionic phosphate moiety of the lipid head-
group (while being more weakly repelled by the cationic
choline moiety; see Wimley et al. (85) Ben-Tal (86)) as well
as being hydrated by the polar H2O molecules, although
hydrogen bonds to tetracaine’s carbonyl oxygen and unpro-
tonated amine nitrogen are possible only in H2O, not lipid
(87). Finally, dipole-dipole interactions are possible between
tetracaine in solution and the mobile, dipolar H2O molecules
and also between tetracaine in the membrane and the strong
membrane dipole ﬁeld caused by the anisotropic alignment
of all the ester bonds of the membrane phospholipids (88)
as well as H2O molecules semiordered at the membrane-
solution interface (81,82). Such dipole ﬁelds have been
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estimated to have potentials of several hundred millivolts
which, even with drug-contained dipoles of fractions of a
debye, would make a substantial contribution to the overall
partition energy (89).
Both hydrophobic and ionic interactions appear to contri-
bute energy to tetracaine’s partitioning. Hydrophobic inter-
actions dominate the overall energetics, as it is well known
that more hydrophobic local anesthetics have a higher mem-
brane partition coefﬁcient (56). Hydrophobic forces proba-
bly also account for the preferred partitioning of both TTC
and TTCH1 into liquid-crystal over solid-gel membranes;
the greater ﬂuidity of the liquid-crystal phase will allow more
intimate associations between the N-buytl-substituted aro-
matic moiety of the drug and the fatty acyl groups of phos-
pholipids (and the larger spacing between phospholipid
headgroups in the liquid crystal will better accommodate the
tertiary amine of the local anesthetic). That adsorption of
tetracaine into the lipid bilayer leads to membrane volume
expansion is supported by the fact that pressure induces ex-
clusion of tetracaine from both model membranes and nerve
membranes (34). Thus, a more expanded membrane is better
able to accommodate the bound drug.
In addition, hydration of the membrane interface is greater
in the liquid-crystal phase (79), allowing charged TTCH1 to
be stabilized by these semimobile H2O molecules. In liquid
crystalline PC the zwitterionic headgroups are aligned more
perpendicular to the membrane surface and bound TTCH1
will reside closer to the negatively charged phosphate. Such
ionic interactions add to the binding energy of TTCH1, even
as hydrophobic factors will reduce it.
In this study, membrane ‘‘ﬂuidity’’ was reduced in two
ways: by a temperature-induced phase transition and by the
inclusion of cholesterol. Both procedures reduced tetracaine’s
partitioning, but they had opposite preferences for the two
species of the drug; liquid-crystal to solid-gel phase transi-
tions lowered the partitioning of charged TTCH1 more than
that of neutral TTC, whereas the addition of cholesterol lowered
the partitioning of the neutral species more than that of the
charged one. These results can be understood by the changes
in membrane dynamics known to be caused by these two pro-
cedures. Solid-gel membranes have both more closely spaced
headgroups and more closely packed acyl chains with less
rotational mobility in the hydrocarbon core of the membrane
than do the liquid-crystal membranes (52). Membranes con-
taining cholesterol, at the mole fraction used here, 0.28, have
less space at the steroid’s location in the region of the phos-
pholipids’ glycerol moiety, ester linkage, and nearer regions
of the acyl chains but have more rotational ﬂuidity near the
ends of the acyl chains in the hydrocarbon core (90).
We interpret the selective reduction of TTCH1’s partition-
ing by solid-gel formation as a reﬂection of the more intimate
interactions of the polar headgroup or of interfacial H2O with
bound TTCH1; condensation of this outer region of the mem-
brane corresponds to more closely packed zwitterionic head-
groups, lying at a more acute angle to the membrane surface,
and the expulsion of some interfacial H2O; for TTCH
1 to
partition into such a membrane requires the disruption of
these PL interactions. The loss of binding energy at this polar
region is larger than the reduction of the hydrophobic bond-
ing of the drug’s aromatic moiety, which is the major factor
in the binding of uncharged TTC, thus accounting for the
larger decrease in partitioning of the charged species upon
solid-gel formation. In contrast, cholesterol causes an ex-
pansion between inner regions of the acyl tails of phospho-
lipids but simultaneously resides in the membrane near the
loci for tetracaine’s hydrophobic and dipole-dipole ﬁeld in-
teractions. Perturbation by cholesterol of polar-charged in-
teractions between PC and tetracaine will be less than its
steric interference at this inner location, resulting in a greater
reduction of binding of neutral TTC than of charged TTCH1.
Cholesterol lowers tetracaine’s binding energy but it does
not change the membrane location of where the drug is most
stable.
According to this analysis, the binding of tetracaine with
membranes below the transition temperature is dominated by
favorable electrostatic interactions and above it by unfavor-
able hydrophobic considerations in water. One would pre-
dict, accordingly, that partitioning into solid-gel membranes
is predominantly an enthalpy-driven process, whereas parti-
tioning into liquid-crystal membranes is predominantly entropy
driven.
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